Reckitt Benckiser Group (LON:RB)‘s stock had its “buy” rating reaffirmed by equities researchers at Liberum Capital in a research note issued on Thursday. They currently have a GBX 7,400 ($102.24) target price on the stock. Liberum Capital’s target price indicates a potential upside of 31.53% from the company’s previous close.
Other research analysts also recently issued reports about the company. JPMorgan Chase & Co. set a GBX 7,500 ($103.62) price target on Reckitt Benckiser Group and gave the stock a “buy” rating in a research note on Wednesday, February 7th. Royal Bank of Canada set a GBX 5,000 ($69.08) price target on Reckitt Benckiser Group and gave the stock a “sell” rating in a research note on Friday, February 23rd. Goldman Sachs set a GBX 6,910 ($95.47) price target on Reckitt Benckiser Group and gave the stock a “neutral” rating in a research note on Thursday, January 25th. BNP Paribas dropped their price target on Reckitt Benckiser Group from GBX 7,400 ($102.24) to GBX 7,200 ($99.47) and set a “neutral” rating on the stock in a research note on Wednesday, January 31st. Finally, Kepler Capital Markets dropped their price target on Reckitt Benckiser Group from GBX 7,300 ($100.86) to GBX 7,000 ($96.71) and set a “hold” rating on the stock in a research note on Monday, January 8th. Two equities research analysts have rated the stock with a sell rating, thirteen have issued a hold rating and nine have assigned a buy rating to the company. The company has a consensus rating of “Hold” and a consensus target price of GBX 7,163.91 ($98.98).
Reckitt Benckiser Group stock opened at GBX 5,626 ($77.73) on Thursday. Reckitt Benckiser Group has a 52 week low of GBX 5,562 ($76.84) and a 52 week high of GBX 8,110.43 ($112.05). The firm has a market capitalization of $39,940.00 and a P/E ratio of 2,045.82.
WARNING: This piece of content was first reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of international trademark and copyright laws. The legal version of this piece of content can be accessed at https://www.dispatchtribunal.com/2018/03/22/reckitt-benckiser-group-rb-receives-buy-rating-from-liberum-capital.html.
About Reckitt Benckiser Group
Reckitt Benckiser Group plc is a manufacturer and marketer of health, hygiene and home products. The Company’s segments include ENA and DvM. The ENA segment consists of Europe, Russia/Commonwealth of Independent States (CIS), Israel, North America, Australia and New Zealand. The DvM segment consists of North Africa, Middle East (excluding Israel) and Turkey, Africa, South Asia, North Asia, Latin America, Japan, Korea and the Association of Southeast Asian Nations (ASEAN).
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.